No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
21 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
42 (estimated)
Sponsor
University of Texas, El Paso · Other
Who this trial is looking for
This trial is looking for people who have had a stroke to see if therapy done at home is as helpful as therapy done in-person. Participants will receive 20 hours of upper body rehabilitation and will be assessed on their recovery at different times after the treatment.
Are You a Good Fit for This Trial?
You may be able to join if
I am 21 years or older
I have had a stroke diagnosed within the last 40 days
I have difficulty using my arm after the stroke
I can follow 2-step commands
I have a score greater than 25 on the Montreal Cognitive Assessment
I am able to participate in follow-up for 1 year
I have no serious memory issues
You may not be able to join if
I cannot give my informed consent
I have a serious ongoing neurological condition
I have had changes in my mental state recently
I currently have active psychosis or substance abuse issues
I have severe sensory loss in my arm
I have extreme uncoordination in my arm
I am pregnant
I have had or will receive botulinum toxin during the study
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can pr…
This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can provide similar benefits to standard in-clinic care.
Participants who recently experienced a stroke will be randomly assigned to receive 20 hours of upper extremity rehabilitation therapy either in person or through a telehealth platform. Both groups will receive the same type and amount of therapy focused on practicing meaningful, patient-selected daily activities. Participants will complete assessments before treatment, immediately after treatment, and at 6 and 12 months to measure recovery of arm function, real-world arm use, and participation in daily life.
The results of this study will help determine whether telerehabilitation can improve access to effective stroke recovery interventions while maintaining clinical effectiveness comparable to in-person therapy.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age 21 years or older
* Neuroimaging-confirmed stroke within 40 days prior to enrollment
* Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item
* Able to participate in all study-related acti…
Inclusion Criteria:
* Age 21 years or older
* Neuroimaging-confirmed stroke within 40 days prior to enrollment
* Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item
* Able to participate in all study-related activities, including 1-year follow-up
* Short Blessed Memory Orientation and Concentration Scale score less than 8
* Able to follow 2-step commands
* Montreal Cognitive Assessment (MoCA) score greater than 25
* No upper extremity injury or condition that limited upper extremity use prior to the stroke
Exclusion Criteria:
* Inability to provide informed consent
* Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication
* Clinically significant fluctuations in mental status within 72 hours prior to randomization
* Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse
* Dense sensory loss, defined by a score of 3 or 4 on the NIH Stroke Scale sensory item
* Ataxia out of proportion to weakness in the affected arm, defined by a score greater than 1 on the NIH Stroke Scale ataxia item
* Not expected to survive 12 months because of other illnesses
* Pregnancy
* Severe aphasia
* Receipt of botulinum toxin or expectation of receiving botulinum toxin during the study period
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
